Related Experiment Video
Updated: Mar 5, 2026

05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
781
Eosinophilic dermatosis of hematologic malignancy
Kathryn Martires1, Shields Callahan, Vitaly Terushkin
1Ronald O. Perelman Department of Dermatology, NYU School of Medicine, NYU Langone Medical Center.
Dermatology Online Journal
|March 23, 2017
Summary
Eosinophilic dermatosis of hematologic malignancy (EDHM) can manifest as itchy, swollen, and blistering skin lesions in patients with chronic lymphocytic leukemia (CLL). Prompt hematologic evaluation is crucial for patients presenting with these dermatologic symptoms.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy.
- Paraneoplastic dermatoses can be associated with underlying malignancies.
- Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare skin condition linked to blood cancers.
Observation:
- A 68-year-old woman with a history of CLL developed pruritic, edematous, and vesicobullous skin lesions on her face and extremities.
- Clinical presentation and histopathologic examination confirmed the diagnosis of EDHM.
- The patient's symptoms developed over several months.
Findings:
- The diagnosis of eosinophilic dermatosis of hematologic malignancy (EDHM) was established based on clinical and histopathological findings.
- EDHM is considered a paraneoplastic disorder resulting from immune dysregulation.
- A potential association between EDHM and more aggressive CLL was noted.
Implications:
- Patients with EDHM require thorough hematologic and oncologic evaluation to assess for underlying or evolving hematologic malignancies.
- Early recognition and management of EDHM may be linked to the control of the underlying cancer.
- Further research into the pathogenesis of EDHM is warranted to understand the immune dysregulation involved.
Related Concept Videos
Disorders of Erythrocytes
2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Skin Diseases and Disorders
5.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.9K
Drug Toxicity: Allergic Reactions
75
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
75
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K

